, while ADA proposed the use of GHb in the definition of diabetes and the category of increased diabetes risk (which also includes impaired fasting glucose and impaired glucose tolerance) in 2010 (5) . Therefore, we investigated whether GHb can be used instead of fasting plasma glucose (FPG) in identifying individuals with MetS.
RESEARCH DESIGN AND
METHODS -Data from the crosssectional U.S. National Health and Nutrition Examination Survey (NHANES) [2003] [2004] [2005] [2006] were used in initial analysis (6) . For confirmation, we used the crosssectional data from NHANES 1999 -2002. All participants gave informed consent, and the study received approval from the Centers for Disease Control and Prevention Institutional Review Board.
MetS was defined using the consensus criteria in 2009 (4) . Under this definition, a person has MetS if he or she meets three or more of the following criteria: 1) central obesity, defined using ethnic-specific cut points of waist circumference, 2) triglycerides Ն150 mg/dl (1.7 mmol/l), 3) HDL cholesterol Ͻ40 mg/dl (1.0 mmol/l) in men and Ͻ50 mg/dl (1.3 mmol/l) in women, 4) blood pressure Ն130/85 mmHg or on antihypertensive medication, or 5) raised blood glucose, defined as FPG Ն100 mg/dl (5.6 mmol/l) or on antidiabetic medication. For nonHispanic whites and blacks, and people of other races and mixed races, the cut points for waist circumference were Ն94 cm in men and Ն80 cm in women. For Mexican Americans and other Hispanics, the cut points were Ն90 cm in men and Ն80 cm in women. In a separate analysis, MetS was defined using the NCEP criteria, which were the same as the consensus criteria in 2009 (4), except that central obesity was defined as waist circumference Ն102 cm in men and Ն88 cm in women (1, 3) . The uses of GHb Ն5.7% or FPG Ն100 mg/dl in the definition of the glycemic component of MetS were compared. Agreement between two definitions was defined as the percentage of participants who were classified the same under both definitions (7, 8) .
The laboratory methods have been described in detail elsewhere (6,8 -11) . Data on GHb and FPG were adjusted so that measurements across survey periods could be combined (6) . History of cardiovascular diseases was obtained from self-reported questionnaires. Statistical analysis was performed using the complex samples function of SPSS version 15.0 (SPSS, Chicago, IL). Fasting sampling weights were used in all analyses to adjust for oversampling and nonresponse bias and to approximate the distribution to the U.S. population in the year 2000.
RESULTS -After excluding pregnant women and subjects with missing data in BMI, GHb, and the five components of MetS, there were 3,551 and 3,412 participants aged Ն20 years in NHANES 1999 -2002 and 2003-2006, respectively, who had fasted for 8 -24 h.
As shown in Table 1 supplementary Tables A1 and  A2 , available in an online appendix at http://care.diabetesjournals.org/cgi/ content/full/dc09-0190/DC1).
Because there is controversy whether the diagnosis of MetS conveys additional meaning in subjects with diabetes who should already be aggressively treated due to high cardiovascular risk, a subgroup without diabetes (non-DM) was also examined. Similar to the overall cohort, in the non-DM group, the use of GHb alone resulted in lower prevalence of MetS compared with FPG alone, with 90.6% agreement (Table 1) . Importantly, in this non-DM subgroup, only the use of GHb alone, but not FPG, resulted in significant association with cardiovascular diseases (odds ratio 1.45, P ϭ 0.005) when the consensus criteria in 2009 was used to define MetS (supplementary Table A3 ).
CONCLUSIONS -The controversy regarding the definition of MetS has been addressed recently in a joint scientific statement (4) . GHb reflects the average blood glucose level over several months, and its measurement does not require a fasting blood sample. In this study, we demonstrated that there was good agreement between GHb and FPG in identifying individuals with MetS, despite only a moderate agreement (ϳ75%) between GHb and FPG in defining raised blood glucose. The components of MetS are inter-correlated; therefore, a certain degree of inaccuracy or fluctuation in one component is tolerated and does not result in misclassification. The agreement between GHb and FPG in the definition of MetS is good in different subgroups. We can therefore confidently conclude that using GHb instead of FPG to define MetS is feasible. This is true at least for Americans, based on the most up-to-date data on a nationally representative sample of Americans, and was confirmed using historical data. It remains to be seen if our conclusions are also applicable to Asians, among whom the prevalence of raised blood glucose is likely to be different.
The current cut point of GHb identifies a slightly smaller group of people as having MetS. However, it also identifies subjects at high risk for cardiovascular diseases, even in those without diabetes, when the consensus criteria in 2009 are used to define MetS. Whether GHb results in better risk stratification needs to be investigated in large prospective studies.
